Farmakoterapia w Psychiatrii i Neurologii

Pełna treść

2/2023 vol. 39
Artykuł przeglądowy

Lit w chorobach afektywnych – aktualizacja

Janusz Rybakowski 1
  1. Poznan University of Medical Sciences, Poznan, Poland; Uniwersytet Medyczny w Poznaniu, Poznań, Polska
Farmakoterapia w Psychiatrii i Neurologii 2023, 39 (2), 103–113
DOI: https://doi.org/10.5114/fpn.2023.131702
Data publikacji online: 2024/01/19
Plik artykułu
02FR_IPiN_FARM_2023-2D.pdf
Confronting perimenopausal women’s knowledge of coronary heart disease with their health behaviours. Controversial role of hormone replacement therapy in the protection of coronary heart disease
  1. Adebiyi O, Peters E, Marcoux G, Alaverdashvili M, Halpape K, Lodhi RJ. A survey of Saskatchewan family physicians, psychiatrists and pharmacists assessing barriers in lithium use. J Affect Disord Rep 2021; 6: 00286.
  2. Almeida OP, Etherton-Beer C, Kelty E, Sanfilippo F, Preen DB, Page A. Lithium dispensed for adults aged ≥ 50 years between 2012 and 2021: Analyses of a 10% sample of the Australian Pharmaceutical Benefits Scheme. Am J Geriatr Psychiatry. 2023; 31: 716-25.
  3. Baastrup PC. The use of lithium in manic-depressive psychoses. Compreh Psychiatry 1964; 5: 396-408.
  4. Bohlken J, Riedel-Heller S, Bauer M, Kostev K. Bipolar disorder and outcomes of monotherapy with lithium, valproate, quetiapine, olanzapine, venlafaxine, and citalopram. Pharmacopsychiatry. 2021; 54: 126-30.
  5. Bosi A, Clase CM, Ceriani L, Sjölander A, Fu EL, Runesson B et al. Absolute and relative risks of kidney outcomes associated with lithium vs valproate use in Sweden. JAMA Netw Open. 2023; 6: e2322056.
  6. Bschor T, Adli M, Alda M, Baethge C, Etain B, Glenn T et al. Letter of response to Nabi Z, Stansfeld J, Plöderl M, Wood L, Moncrieff J. Effects of lithium on suicide and suicidal behaviour: a systematic review and meta-analysis of randomised trials. Epidemiol Psychiatr Sci. 2022; 31: e84.
  7. Buspavanich P, Behr J, Stamm T, Schlattmann P, Bschor T, Richter C et al. Treatment response of lithium augmentation in geriatric compared to non-geriatric patients with treatment-resistant depression. J Affect Disord. 2019; 251: 136-140.
  8. Cade JFK. Lithium salts in the treatment of psychotic excitement. Med J Aust 1949; 36: 349-52.
  9. Chen PH, Tsai SY, Chen PY, Pan CH, Su SS, Chen CC et al. Mood stabilizers and risk of all-cause, natural, and suicide mortality in bipolar disorder: A nationwide cohort study. Acta Psychiatr Scand. 2023a; 147: 234-47.
  10. Chen PH, Hsiao CY, Chiang SJ, Shen RS, Lin YK, Chung KH, Tsai SY. Cardioprotective potential of lithium and role of fractalkine in euthymic patients with bipolar disorder. Aust N Z J Psychiatry. 2023b; 57: 104-14.
  11. Chen PH, Hsiao CY, Chiang SJ, Tsai SY. Association of lithium treatment with reduced left ventricular concentricity in patients with bipolar disorder. Psychiatry Clin Neurosci. 2023c; 77: 59-61.
  12. Chen PH, Tsai SY, Pan CH, Chang CK, Su SS, Chen CC et al. Mood stabilisers and risk of stroke in bipolar disorder. Br J Psychiatry. 2019; 215: 409-14.
  13. Chen S, Underwood BR, Jones PB, Lewis JR, Cardinal RN. Association between lithium use and the incidence of dementia and its subtypes: A retrospective cohort study. PLoS Med. 2022; 19: e1003941.
  14. De Montigny C, Grunberg F, Mayer A, Deschenes JP. Lithium induces rapid relief of depression in tricyclic antidepressant nonresponders. Br J Psychiatry 1981; 138: 252-6.
  15. Del Matto L, Muscas M, Murru A, Verdolini N, Anmella G, Fico G et al. Lithium and suicide prevention in mood disorders and in the general population: A systematic review. Neurosci Biobehav Rev. 2020; 116: 142-53.
  16. Díaz-Zuluaga AM, Vélez JI, Cuartas M, Valencia J, Castaño M, Palacio JD et al. Ancestry component as a major predictor of lithium response in the treatment of bipolar disorder. J Affect Disord. 2023; 332: 203-9.
  17. Ercis M, Ozerdem A, Singh B. When and how to use lithium augmentation for treating major depressive disorder. J Clin Psychiatry. 2023; 84: 23ac14813.
  18. Ferensztajn-Rochowiak E, Chłopocka-Woźniak M, Rybakowski JK. Ultra-long-term lithium therapy: all-important matters and a case of successful 50-year lithium treatment. Braz J Psychiatry. 2021; 43: 407-13.
  19. Ferensztajn-Rochowiak E, Rybakowski JK. Long-term lithium therapy: side effects and interactions. Pharmaceuticals 2023; 16: 74.
  20. Fico G, Anmella G, Gomez-Ramiro M, de Miquel C, Hidalgo-Mazzei D, Manchia M et al. Duration of untreated illness and bipolar disorder: time for a new definition? Results from a cross-sectional study. J Affect Disord. 2021; 294: 513-20.
  21. Findling RL, McNamara NK, Pavuluri M, Frazier JA, Rynn M, Scheffer R et al. Lithium for the maintenance treatment of bipolar I disorder: A double-blind, placebo-controlled discontinuation study. J Am Acad Child Adolesc Psychiatry 2019; 58: 287-96.e4
  22. Fornaro M, Maritan E, Ferranti R, Zaninotto L, Miola A, Anastasia A et al. Lithium exposure during pregnancy and the postpartum period: a systematic review and meta-analysis of safety and efficacy outcomes. Am J Psychiatry. 2020; 177: 76-92.
  23. Fountoulakis KN, Tohen M, Zarate CA Jr. Lithium treatment of Bipolar disorder in adults: A systematic review of randomized trials and meta-analyses. Eur Neuropsychopharmacol. 2022; 54: 100-15.
  24. Gomes-da-Costa S, Marx W, Corponi F, Anmella G, Murru A, Pons-Cabrera MT et al. Lithium therapy and weight change in people with bipolar disorder: A systematic review and meta-analysis. Neurosci Biobehav Rev. 2022; 134: 104266.
  25. Gomes FA, Brietzke E, Bauer M, Post RM. A call for improving lithium literacy among clinicians and patients. Int J Bipolar Disord. 2022; 10: 5
  26. Gomes FA, Soleas EK, Kcomt A, Duffy A, Milev R, Post RM et al. Practices, knowledge, and attitudes about lithium treatment: Results of online surveys completed by clinicians and lithium-treated patients. Psychiatr Res. 2023; 164: 335-43.
  27. Greil W, Bardeci M, Müller-Oerlinghausen B, Nievergelt N, Stassen H, Hasler G et al. Controversies regarding Lithium-associated weight gain: case-control study of real-world drug safety data. Int J Bipol Disord 2023; 11: (w druku).
  28. Grillault Laroche D, Etain B, Severus E, Scott J, Bellivier F; ISBD-IGSLI Joint Task Force on Lithium Treatment. Socio-demographic and clinical predictors of outcome to long-term treatment with lithium in bipolar disorders: a systematic review of the contemporary literature and recommendations from the ISBD/IGSLI Task Force on treatment with lithium. Int J Bipolar Disord. 2020; 8: 40.
  29. Güneş H, Tanıdır C, Doktur H, Karaçetin G, Kılıçoğlu AG, Yalçın Ö et al. Long-term effects of lithium use on children and adolescents: a retrospective study from Turkey. J Child Adolesc Psychopharmacol. 2022; 32: 162-70.
  30. Hafeman DM, Rooks B, Merranko J, Liao F, Gill MK, Goldstein TR et al. Lithium versus other mood-stabilizing medications in a longitudinal study of youth diagnosed with bipolar disorder. J Am Acad Child Adolesc Psychiatry. 2020; 59:1146-55.
  31. Hartigan GP. The use of lithium salts in affective disorders. Br J Psychiatry 1963; 109: 810-14.
  32. Hidalgo-Mazzei D, Mantingh T, Pérez de Mendiola X, Samalin L, Undurraga J, Strejilevich S et al. Clinicians' preferences and attitudes towards the use of lithium in the maintenance treatment of bipolar disorders around the world: a survey from the ISBD Lithium task force. Int J Bipolar Disord. 2023; 11: 20.
  33. Hsu CW, Carvalho AF, Tsai SY, Wang LJ, Tseng PT, Lin PY et al. Lithium concentration and recurrence risk during maintenance treatment of bipolar disorder: Multicenter cohort and meta-analysis. Acta Psychiatr Scand. 2021; 144: 368-78.
  34. Hsu CW, Tsai SY, Tseng PT, Liang CS, Vieta E, Carvalho AF et al. Differences in the prophylactic effect of serum lithium levels on depression and mania in bipolar disorder: A dose-response meta-analysis. Eur Neuropsychopharmacol. 2022; 58: 20-9.
  35. Izsak B, Hidvegi A, Balint L, Malnasi T, Vargha M, Pandics T et al. Investigation of the association between lithium levels in drinking water and suicide mortality in Hungary. J Affect Disord. 2022; 298(Pt A): 540-47.
  36. Köhler-Forsberg O, Rohde C, Nierenberg AA, Østergaard SD. Association of lithium treatment with the risk of osteoporosis in patients with bipolar disorder. JAMA Psychiatry. 2022; 79: 454-63.
  37. Kraszewska A, Ziemnicka K, Jończyk-Potoczna K, Sowiński J, Rybakowski JK. Thyroid structure and function in long-term lithium-treated and lithium-naïve bipolar patients. Hum Psychopharmacol. 2019; 34: e2708
  38. Liaugaudaite V, Raskauskiene N, Naginiene R, Mickuviene N, Sher L. Association between lithium levels in drinking water and suicide rates: Role of affective disorders. J Affect Disord. 2022; 298(Pt A): 516-21.
  39. Lin Y, Maihofer AX, Stapp E, Ritchey M, Alliey-Rodriguez N, Anand A et al. Clinical predictors of non-response to lithium treatment in the Pharmacogenomics of Bipolar Disorder (PGBD) study. Bipolar Disord. 2021 Dec; 23 (8): 821-31.
  40. López Steinmetz LC, López Steinmetz RL, Diaz SL, Godoy JC. Lithium in drinking water, altitude, and suicide rates in rural areas of Argentinean Andes. Spat Spatiotemporal Epidemiol. 2021; 36: 100393.
  41. Malhi GS, Bauer M. Lithium first: Not merely first line. Bipolar Disord. 2023; 25: 7-8.
  42. McKnight RF, de La Motte de Broöns de Vauvert SJGN, Chesney E, Amit BH, Geddes J, Cipriani A. Lithium for acute mania. Cochrane Database Syst Rev. 2019; 6: CD004048.
  43. Moncrieff J, Cooper RE, Stockmann T, Amendola S, Hengartner MP, Horowitz MA. The serotonin theory of depression: a systematic umbrella review of the evidence. Mol Psychiatry. 2022 Jul 20. doi: 10.1038/s41380-022-01661-0. Online ahead of print.
  44. Nabi Z, Stansfeld J, Plöderl M, Wood L, Moncrieff J. Effects of lithium on suicide and suicidal behaviour: a systematic review and meta-analysis of randomised trials. Epidemiol Psychiatr Sci. 2022; 31: e65.
  45. Ng VWS, Leung MTY, Chan EW, Lee EHM, Hayes JF, Osborn DPJ et al. Association between the mood stabilizing treatment of bipolar disorder and risk of suicide attempts: A self-controlled case series study. Psychiatry Res. 2023; 325: 115236.
  46. Nieper HA. The clinical applications of lithium orotate. A two years study. Agressologie. 1973; 14: 407-11.
  47. Nolen WA, Licht RW, Young AH, Malhi GS, Tohen M, Vieta E et al. What is the optimal serum level for lithium in the maintenance treatment of bipolar disorder? A systematic review and recommendations from the ISBD/IGSLI Task Force on treatment with lithium. Bipolar Disord 2019; 21: 394-09.
  48. Pacholko AG, Bekar LK. Different pharmacokinetics of lithium orotate inform why it is more potent, effective, and less toxic than lithium carbonate in a mouse model of mania. J Psychiatr Res. 2023; 164: 192-201.
  49. Palmer A, Cates ME, Gorman G. The association between lithium in drinking water and incidence of suicide across 15 Alabama counties. Crisis. 2019; 40: 93-9.
  50. Pelacchi F, Dell’Osso L, Bondi E, Amore M, Fagiolini A, Iazzetta P et al. Clinical evaluation of switching from immediate-release to prolonged-release lithium in bipolar patients, poorly tolerant to lithium immediate-release treatment: A randomized clinical trial. Brain Behav. 2022; 12: e2485.
  51. Pérez de Mendiola X, Hidalgo-Mazzei D, Vieta E, González-Pinto A. Overview of lithium’s use: a nationwide survey. Int J Bipolar Disord. 2021; 9: 10.
  52. Poels EM, Sterrenburg K, Wierdsma AI, Wesseloo R, Beerthuizen A, van Dijke L et al. Lithium exposure during pregnancy increases fetal growth. J Psychopharmacol. 2021; 35: 178-83.
  53. Poels EMP, Schrijver L, White TJH, Roza SJ, Zarchev MG, Bijma H et al. The effect of prenatal lithium exposure on the neuropsychological development of the child. Bipolar Disord. 2022; 24: 310-19.
  54. Poels EMP, Kamperman AM, Bijma HH, Honig A, van Kamp IL, Kushner SA et al. Brain development after intrauterine exposure to lithium: A magnetic resonance imaging study in school-age children. Bipolar Disord. 2023; 25: 181-90.
  55. Ponzer K, Millischer V, Schalling M, Gissler M, Lavebratt C, Backlund L. Lithium and risk of cardiovascular disease, dementia and venous thromboembolism. Bipolar Disord. 2023 Jan 18. doi: 10.1111/bdi.13300. Online ahead of print.
  56. Rhee TG, Olfson M, Nierenberg AA, Wilkinson ST. 20-year trends in the pharmacologic treatment of bipolar disorder by psychiatrists in outpatient care settings. Am J Psychiatry. 2020; 177: 706-15.
  57. Rohde C, Köhler-Forsberg O, Nierenberg AA, Østergaard SD. Pharmacological treatment of bipolar disorder and risk of diabetes mellitus: A nationwide study of 30,451 patients. Bipolar Disord. 2023; 25: 323-34.
  58. Romo-Nava F, Blom T, Cuellar-Barboza AB, Barrera FJ, Miola A, Mori NN et al. Clinical characterization of patients with bipolar disorder and a history of asthma: An exploratory study. J Psychiatr Res. 2023; 164: 8-14.
  59. Rybakowski J, Chłopocka M, Lisowska J, Czerwiński A. Badania nad skutecznością leczniczą węglanu litu w endogennych zespołach depresyjnych. Psychiatr Pol 1974; 8: 129-35.
  60. Rybakowski J. Leczenie litem – stan wiedzy na rok 2020. Psychiatr Pol 2020; 54: 1047-66.
  61. Rybakowski J. Lit – niezwykły lek w psychiatrii. Wydawnictwo Termedia, Poznań, 2019. https://www.termedia.pl/Ksiazka/-279
  62. Rybakowski JK, Ferensztajn-Rochowiak E. Mini-review: Anomalous association between lithium data and lithium use. Neurosci Lett. 2022; 777: 136590.
  63. Rybakowski JK, Ferensztajn-Rochowiak E. Updated perspectives on how and when lithium should be used in the treatment of mood disorders. Expert Rev Neurother 2023; 23: 157-167.
  64. Sagué-Vilavella M, Solé E, Pinzón-Espinosa J, Sandra-Hernández A, Roda E, Vieta E, Roca A. Obstetric outcomes regarding the use of lithium in pregnant women with bipolar disorders: a prospective cohort study. Arch Womens Ment Health. 2022; 25: 729-37.
  65. Scherf-Clavel M, Treiber S, Deckert J, Unterecker S, Hommers L. Drug-drug interactions between lithium and cardiovascular as well as anti-inflammatory drugs. Pharmacopsychiatry. 2020; 53: 229-34.
  66. Schonewille NN, Terpstra PA, van den Heuvel MEN, Van Pampus MG, van den Heuvel OA, Broekman BFP. Neonatal admission after lithium use in pregnant women with bipolar disorders: a retrospective cohort study. Int J Bipolar Disord. 2023; 11: 24.
  67. Schoot TS, Molmans THJ, Grootens KP, Kerckhoffs APM. Systematic review and practical guideline for the prevention and management of the renal side effects of lithium therapy. Eur Neuropsychopharmacol. 2020; 31: 16-32.
  68. Schoretsanitis G, de Filippis R, Brady BM, Homan P, Suppes T, Kane JM. Prevalence of impaired kidney function in patients with long-term lithium treatment: A systematic review and meta-analysis. Bipolar Disord. 2022; 24: 264-74.
  69. Shafiq S, Ronksley PE, Scory TD, Elliott MJ, Bulloch AGM, Patten SB. Ten-year trends in lithium prescribing in Alberta, Canada. Can J Psychiatry. 2023: 7067437231176905. doi: 10.1177/07067437231176905. Online ahead of print.
  70. Shulman KI, Almeida OP, Herrmann N, Schaffer A, Strejilevich SA, Paternoster C et al. Delphi survey of maintenance lithium treatment in older adults with bipolar disorder: An ISBD task force report. Bipolar Disord. 2019; 21: 117-23.
  71. Singh B, Yocum AK, Strawbridge R, Burdick KE, Millett CE, Peters AT et al. Patterns of pharmacotherapy for bipolar disorder: A GBC survey. Bipolar Disord. 2023 Jul 18. doi: 10.1111/bdi.13366. Online ahead of print.
  72. Undurraga J, Sim K, Tondo L, Gorodischer A, Azua E, Tay KH et al. Lithium treatment for unipolar major depressive disorder: Systematic review. J Psychopharmacol 2019; 33: 167-76.
  73. Velosa J, Delgado A, Finger E, Berk M, Kapczinski F, de Azevedo Cardoso T. Risk of dementia in bipolar disorder and the interplay of lithium: a systematic review and meta-analyses. Acta Psychiatr Scand. 2020; 141: 510-21.
ZGŁASZANIE PRAC
Udostępnij
without publication fees
without publication fees
Zintergrowane z
Zasady redakcyjne
Sarajevo Declaration on Integrity and Visibility of Scholarly Publications